PharmEasy will raise ₹3,500 crore through rights issue next week, helping it repay a big chunk of its loans to Goldman Sachs, Mint reported. Temasek Holdings, TPG, Prosus, CDPQ, Eight Roads, LGT, Abu Dhabi's ADQ, Amansa, OrbiMed and Sunil Kant Munjal's family office have committed to invest ₹2,000 crore. The issue is priced at pre-money valuation of around $500 million.